Global Gastrointestinal Market Size, Status and Forecast 2020-2026
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gastrointestinal market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gastrointestinal industry.
Based on our recent survey, we have several different scenarios about the Gastrointestinal YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 34140 million in 2019. The market size of Gastrointestinal will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal market in terms of revenue.
Players, stakeholders, and other participants in the global Gastrointestinal market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gastrointestinal market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gastrointestinal market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal market.
The following players are covered in this report:
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gastrointestinal market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gastrointestinal industry.
Based on our recent survey, we have several different scenarios about the Gastrointestinal YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 34140 million in 2019. The market size of Gastrointestinal will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal market in terms of revenue.
Players, stakeholders, and other participants in the global Gastrointestinal market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gastrointestinal market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gastrointestinal market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal market.
The following players are covered in this report:
- AstraZenec
- Sanofi
- Bayer
- Pfizer
- GlaxoSmithKline
- Teva
- Zeria?Tillotts?
- Perrigo
- Boehringer Ingelheim
- Purdue Pharma
- C.B. Fleet
- Abbott
- Jiangzhong
- Xian-Janssen
- Prescription Gastrointestinal Drug
- OTC Gastrointestinal Drug
- Chronic Gastritis
- Functional Dyspepsia
- Peptic Ulcer
- Acute Gastroenteritis
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Revenue
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prescription Gastrointestinal Drug
1.4.3 OTC Gastrointestinal Drug
1.5 Market by Application
1.5.1 Global Gastrointestinal Market Share by Application: 2020 VS 2026
1.5.2 Chronic Gastritis
1.5.3 Functional Dyspepsia
1.5.4 Peptic Ulcer
1.5.5 Acute Gastroenteritis
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gastrointestinal Industry Impact
1.6.1 How the Covid-19 is Affecting the Gastrointestinal Industry
1.6.1.1 Gastrointestinal Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gastrointestinal Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gastrointestinal Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gastrointestinal Market Perspective (2015-2026)
2.2 Gastrointestinal Growth Trends by Regions
2.2.1 Gastrointestinal Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gastrointestinal Players by Market Size
3.1.1 Global Top Gastrointestinal Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Market Concentration Ratio
3.2.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2019
3.3 Gastrointestinal Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Product Solution and Service
3.5 Date of Enter into Gastrointestinal Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gastrointestinal Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2021-2026)
5 GASTROINTESTINAL BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gastrointestinal Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gastrointestinal Market Size (2015-2020)
6.2 Gastrointestinal Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gastrointestinal Market Size (2015-2020)
7.2 Gastrointestinal Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Market Size by Application (2015-2020)
8 CHINA
8.1 China Gastrointestinal Market Size (2015-2020)
8.2 Gastrointestinal Key Players in China (2019-2020)
8.3 China Gastrointestinal Market Size by Type (2015-2020)
8.4 China Gastrointestinal Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gastrointestinal Market Size (2015-2020)
9.2 Gastrointestinal Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gastrointestinal Market Size (2015-2020)
10.2 Gastrointestinal Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Market Size by Application (2015-2020)
11 INDIA
11.1 India Gastrointestinal Market Size (2015-2020)
11.2 Gastrointestinal Key Players in India (2019-2020)
11.3 India Gastrointestinal Market Size by Type (2015-2020)
11.4 India Gastrointestinal Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gastrointestinal Market Size (2015-2020)
12.2 Gastrointestinal Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 AstraZenec
13.1.1 AstraZenec Company Details
13.1.2 AstraZenec Business Overview and Its Total Revenue
13.1.3 AstraZenec Gastrointestinal Introduction
13.1.4 AstraZenec Revenue in Gastrointestinal Business (2015-2020))
13.1.5 AstraZenec Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Gastrointestinal Introduction
13.2.4 Sanofi Revenue in Gastrointestinal Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview and Its Total Revenue
13.3.3 Bayer Gastrointestinal Introduction
13.3.4 Bayer Revenue in Gastrointestinal Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview and Its Total Revenue
13.4.3 Pfizer Gastrointestinal Introduction
13.4.4 Pfizer Revenue in Gastrointestinal Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Gastrointestinal Introduction
13.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Teva
13.6.1 Teva Company Details
13.6.2 Teva Business Overview and Its Total Revenue
13.6.3 Teva Gastrointestinal Introduction
13.6.4 Teva Revenue in Gastrointestinal Business (2015-2020)
13.6.5 Teva Recent Development
13.7 Zeria?Tillotts?
13.7.1 Zeria?Tillotts? Company Details
13.7.2 Zeria?Tillotts? Business Overview and Its Total Revenue
13.7.3 Zeria?Tillotts? Gastrointestinal Introduction
13.7.4 Zeria?Tillotts? Revenue in Gastrointestinal Business (2015-2020)
13.7.5 Zeria?Tillotts? Recent Development
13.8 Perrigo
13.8.1 Perrigo Company Details
13.8.2 Perrigo Business Overview and Its Total Revenue
13.8.3 Perrigo Gastrointestinal Introduction
13.8.4 Perrigo Revenue in Gastrointestinal Business (2015-2020)
13.8.5 Perrigo Recent Development
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Details
13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.9.3 Boehringer Ingelheim Gastrointestinal Introduction
13.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2015-2020)
13.9.5 Boehringer Ingelheim Recent Development
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Details
13.10.2 Purdue Pharma Business Overview and Its Total Revenue
13.10.3 Purdue Pharma Gastrointestinal Introduction
13.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2015-2020)
13.10.5 Purdue Pharma Recent Development
13.11 C.B. Fleet
10.11.1 C.B. Fleet Company Details
10.11.2 C.B. Fleet Business Overview and Its Total Revenue
10.11.3 C.B. Fleet Gastrointestinal Introduction
10.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2015-2020)
10.11.5 C.B. Fleet Recent Development
13.12 Abbott
10.12.1 Abbott Company Details
10.12.2 Abbott Business Overview and Its Total Revenue
10.12.3 Abbott Gastrointestinal Introduction
10.12.4 Abbott Revenue in Gastrointestinal Business (2015-2020)
10.12.5 Abbott Recent Development
13.13 Jiangzhong
10.13.1 Jiangzhong Company Details
10.13.2 Jiangzhong Business Overview and Its Total Revenue
10.13.3 Jiangzhong Gastrointestinal Introduction
10.13.4 Jiangzhong Revenue in Gastrointestinal Business (2015-2020)
10.13.5 Jiangzhong Recent Development
13.14 Xian-Janssen
10.14.1 Xian-Janssen Company Details
10.14.2 Xian-Janssen Business Overview and Its Total Revenue
10.14.3 Xian-Janssen Gastrointestinal Introduction
10.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2015-2020)
10.14.5 Xian-Janssen Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Revenue
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prescription Gastrointestinal Drug
1.4.3 OTC Gastrointestinal Drug
1.5 Market by Application
1.5.1 Global Gastrointestinal Market Share by Application: 2020 VS 2026
1.5.2 Chronic Gastritis
1.5.3 Functional Dyspepsia
1.5.4 Peptic Ulcer
1.5.5 Acute Gastroenteritis
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gastrointestinal Industry Impact
1.6.1 How the Covid-19 is Affecting the Gastrointestinal Industry
1.6.1.1 Gastrointestinal Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gastrointestinal Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gastrointestinal Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gastrointestinal Market Perspective (2015-2026)
2.2 Gastrointestinal Growth Trends by Regions
2.2.1 Gastrointestinal Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gastrointestinal Players by Market Size
3.1.1 Global Top Gastrointestinal Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Market Concentration Ratio
3.2.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2019
3.3 Gastrointestinal Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Product Solution and Service
3.5 Date of Enter into Gastrointestinal Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gastrointestinal Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2021-2026)
5 GASTROINTESTINAL BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gastrointestinal Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gastrointestinal Market Size (2015-2020)
6.2 Gastrointestinal Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gastrointestinal Market Size (2015-2020)
7.2 Gastrointestinal Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Market Size by Application (2015-2020)
8 CHINA
8.1 China Gastrointestinal Market Size (2015-2020)
8.2 Gastrointestinal Key Players in China (2019-2020)
8.3 China Gastrointestinal Market Size by Type (2015-2020)
8.4 China Gastrointestinal Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gastrointestinal Market Size (2015-2020)
9.2 Gastrointestinal Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gastrointestinal Market Size (2015-2020)
10.2 Gastrointestinal Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Market Size by Application (2015-2020)
11 INDIA
11.1 India Gastrointestinal Market Size (2015-2020)
11.2 Gastrointestinal Key Players in India (2019-2020)
11.3 India Gastrointestinal Market Size by Type (2015-2020)
11.4 India Gastrointestinal Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gastrointestinal Market Size (2015-2020)
12.2 Gastrointestinal Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 AstraZenec
13.1.1 AstraZenec Company Details
13.1.2 AstraZenec Business Overview and Its Total Revenue
13.1.3 AstraZenec Gastrointestinal Introduction
13.1.4 AstraZenec Revenue in Gastrointestinal Business (2015-2020))
13.1.5 AstraZenec Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Gastrointestinal Introduction
13.2.4 Sanofi Revenue in Gastrointestinal Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview and Its Total Revenue
13.3.3 Bayer Gastrointestinal Introduction
13.3.4 Bayer Revenue in Gastrointestinal Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview and Its Total Revenue
13.4.3 Pfizer Gastrointestinal Introduction
13.4.4 Pfizer Revenue in Gastrointestinal Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Gastrointestinal Introduction
13.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Teva
13.6.1 Teva Company Details
13.6.2 Teva Business Overview and Its Total Revenue
13.6.3 Teva Gastrointestinal Introduction
13.6.4 Teva Revenue in Gastrointestinal Business (2015-2020)
13.6.5 Teva Recent Development
13.7 Zeria?Tillotts?
13.7.1 Zeria?Tillotts? Company Details
13.7.2 Zeria?Tillotts? Business Overview and Its Total Revenue
13.7.3 Zeria?Tillotts? Gastrointestinal Introduction
13.7.4 Zeria?Tillotts? Revenue in Gastrointestinal Business (2015-2020)
13.7.5 Zeria?Tillotts? Recent Development
13.8 Perrigo
13.8.1 Perrigo Company Details
13.8.2 Perrigo Business Overview and Its Total Revenue
13.8.3 Perrigo Gastrointestinal Introduction
13.8.4 Perrigo Revenue in Gastrointestinal Business (2015-2020)
13.8.5 Perrigo Recent Development
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Details
13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.9.3 Boehringer Ingelheim Gastrointestinal Introduction
13.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2015-2020)
13.9.5 Boehringer Ingelheim Recent Development
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Details
13.10.2 Purdue Pharma Business Overview and Its Total Revenue
13.10.3 Purdue Pharma Gastrointestinal Introduction
13.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2015-2020)
13.10.5 Purdue Pharma Recent Development
13.11 C.B. Fleet
10.11.1 C.B. Fleet Company Details
10.11.2 C.B. Fleet Business Overview and Its Total Revenue
10.11.3 C.B. Fleet Gastrointestinal Introduction
10.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2015-2020)
10.11.5 C.B. Fleet Recent Development
13.12 Abbott
10.12.1 Abbott Company Details
10.12.2 Abbott Business Overview and Its Total Revenue
10.12.3 Abbott Gastrointestinal Introduction
10.12.4 Abbott Revenue in Gastrointestinal Business (2015-2020)
10.12.5 Abbott Recent Development
13.13 Jiangzhong
10.13.1 Jiangzhong Company Details
10.13.2 Jiangzhong Business Overview and Its Total Revenue
10.13.3 Jiangzhong Gastrointestinal Introduction
10.13.4 Jiangzhong Revenue in Gastrointestinal Business (2015-2020)
10.13.5 Jiangzhong Recent Development
13.14 Xian-Janssen
10.14.1 Xian-Janssen Company Details
10.14.2 Xian-Janssen Business Overview and Its Total Revenue
10.14.3 Xian-Janssen Gastrointestinal Introduction
10.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2015-2020)
10.14.5 Xian-Janssen Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Gastrointestinal Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Revenue
Table 3. Ranking of Global Top Gastrointestinal Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prescription Gastrointestinal Drug
Table 6. Key Players of OTC Gastrointestinal Drug
Table 7. COVID-19 Impact Global Market: (Four Gastrointestinal Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gastrointestinal Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gastrointestinal Players to Combat Covid-19 Impact
Table 12. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gastrointestinal Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gastrointestinal Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gastrointestinal Market Share by Regions (2015-2020)
Table 16. Global Gastrointestinal Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gastrointestinal Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gastrointestinal Market Growth Strategy
Table 22. Main Points Interviewed from Key Gastrointestinal Players
Table 23. Global Gastrointestinal Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gastrointestinal Market Share by Players (2015-2020)
Table 25. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal as of 2019)
Table 26. Global Gastrointestinal by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gastrointestinal Product Solution and Service
Table 29. Date of Enter into Gastrointestinal Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gastrointestinal Market Size Share by Type (2015-2020)
Table 33. Global Gastrointestinal Revenue Market Share by Type (2021-2026)
Table 34. Global Gastrointestinal Market Size Share by Application (2015-2020)
Table 35. Global Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gastrointestinal Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gastrointestinal Market Share (2019-2020)
Table 39. North America Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gastrointestinal Market Share by Type (2015-2020)
Table 41. North America Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gastrointestinal Market Share by Application (2015-2020)
Table 43. Europe Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gastrointestinal Market Share (2019-2020)
Table 45. Europe Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gastrointestinal Market Share by Type (2015-2020)
Table 47. Europe Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gastrointestinal Market Share by Application (2015-2020)
Table 49. China Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gastrointestinal Market Share (2019-2020)
Table 51. China Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 52. China Gastrointestinal Market Share by Type (2015-2020)
Table 53. China Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 54. China Gastrointestinal Market Share by Application (2015-2020)
Table 55. Japan Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gastrointestinal Market Share (2019-2020)
Table 57. Japan Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gastrointestinal Market Share by Type (2015-2020)
Table 59. Japan Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gastrointestinal Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gastrointestinal Market Share (2019-2020)
Table 63. Southeast Asia Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gastrointestinal Market Share by Type (2015-2020)
Table 65. Southeast Asia Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gastrointestinal Market Share by Application (2015-2020)
Table 67. India Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gastrointestinal Market Share (2019-2020)
Table 69. India Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 70. India Gastrointestinal Market Share by Type (2015-2020)
Table 71. India Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 72. India Gastrointestinal Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gastrointestinal Market Share (2019-2020)
Table 75. Central & South America Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gastrointestinal Market Share by Type (2015-2020)
Table 77. Central & South America Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gastrointestinal Market Share by Application (2015-2020)
Table 79. AstraZenec Company Details
Table 80. AstraZenec Business Overview
Table 81. AstraZenec Product
Table 82. AstraZenec Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 83. AstraZenec Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Product
Table 92. Bayer Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 93. Bayer Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Teva Company Details
Table 105. Teva Business Overview
Table 106. Teva Product
Table 107. Teva Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 108. Teva Recent Development
Table 109. Zeria?Tillotts? Company Details
Table 110. Zeria?Tillotts? Business Overview
Table 111. Zeria?Tillotts? Product
Table 112. Zeria?Tillotts? Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 113. Zeria?Tillotts? Recent Development
Table 114. Perrigo Business Overview
Table 115. Perrigo Product
Table 116. Perrigo Company Details
Table 117. Perrigo Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 118. Perrigo Recent Development
Table 119. Boehringer Ingelheim Company Details
Table 120. Boehringer Ingelheim Business Overview
Table 121. Boehringer Ingelheim Product
Table 122. Boehringer Ingelheim Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 123. Boehringer Ingelheim Recent Development
Table 124. Purdue Pharma Company Details
Table 125. Purdue Pharma Business Overview
Table 126. Purdue Pharma Product
Table 127. Purdue Pharma Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 128. Purdue Pharma Recent Development
Table 129. C.B. Fleet Company Details
Table 130. C.B. Fleet Business Overview
Table 131. C.B. Fleet Product
Table 132. C.B. Fleet Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 133. C.B. Fleet Recent Development
Table 134. Abbott Company Details
Table 135. Abbott Business Overview
Table 136. Abbott Product
Table 137. Abbott Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 138. Abbott Recent Development
Table 139. Jiangzhong Company Details
Table 140. Jiangzhong Business Overview
Table 141. Jiangzhong Product
Table 142. Jiangzhong Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 143. Jiangzhong Recent Development
Table 144. Xian-Janssen Company Details
Table 145. Xian-Janssen Business Overview
Table 146. Xian-Janssen Product
Table 147. Xian-Janssen Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 148. Xian-Janssen Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 1. Gastrointestinal Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Revenue
Table 3. Ranking of Global Top Gastrointestinal Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prescription Gastrointestinal Drug
Table 6. Key Players of OTC Gastrointestinal Drug
Table 7. COVID-19 Impact Global Market: (Four Gastrointestinal Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gastrointestinal Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gastrointestinal Players to Combat Covid-19 Impact
Table 12. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gastrointestinal Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gastrointestinal Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gastrointestinal Market Share by Regions (2015-2020)
Table 16. Global Gastrointestinal Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gastrointestinal Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gastrointestinal Market Growth Strategy
Table 22. Main Points Interviewed from Key Gastrointestinal Players
Table 23. Global Gastrointestinal Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gastrointestinal Market Share by Players (2015-2020)
Table 25. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal as of 2019)
Table 26. Global Gastrointestinal by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gastrointestinal Product Solution and Service
Table 29. Date of Enter into Gastrointestinal Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gastrointestinal Market Size Share by Type (2015-2020)
Table 33. Global Gastrointestinal Revenue Market Share by Type (2021-2026)
Table 34. Global Gastrointestinal Market Size Share by Application (2015-2020)
Table 35. Global Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gastrointestinal Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gastrointestinal Market Share (2019-2020)
Table 39. North America Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gastrointestinal Market Share by Type (2015-2020)
Table 41. North America Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gastrointestinal Market Share by Application (2015-2020)
Table 43. Europe Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gastrointestinal Market Share (2019-2020)
Table 45. Europe Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gastrointestinal Market Share by Type (2015-2020)
Table 47. Europe Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gastrointestinal Market Share by Application (2015-2020)
Table 49. China Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gastrointestinal Market Share (2019-2020)
Table 51. China Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 52. China Gastrointestinal Market Share by Type (2015-2020)
Table 53. China Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 54. China Gastrointestinal Market Share by Application (2015-2020)
Table 55. Japan Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gastrointestinal Market Share (2019-2020)
Table 57. Japan Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gastrointestinal Market Share by Type (2015-2020)
Table 59. Japan Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gastrointestinal Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gastrointestinal Market Share (2019-2020)
Table 63. Southeast Asia Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gastrointestinal Market Share by Type (2015-2020)
Table 65. Southeast Asia Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gastrointestinal Market Share by Application (2015-2020)
Table 67. India Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gastrointestinal Market Share (2019-2020)
Table 69. India Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 70. India Gastrointestinal Market Share by Type (2015-2020)
Table 71. India Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 72. India Gastrointestinal Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gastrointestinal Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gastrointestinal Market Share (2019-2020)
Table 75. Central & South America Gastrointestinal Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gastrointestinal Market Share by Type (2015-2020)
Table 77. Central & South America Gastrointestinal Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gastrointestinal Market Share by Application (2015-2020)
Table 79. AstraZenec Company Details
Table 80. AstraZenec Business Overview
Table 81. AstraZenec Product
Table 82. AstraZenec Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 83. AstraZenec Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Product
Table 92. Bayer Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 93. Bayer Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Teva Company Details
Table 105. Teva Business Overview
Table 106. Teva Product
Table 107. Teva Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 108. Teva Recent Development
Table 109. Zeria?Tillotts? Company Details
Table 110. Zeria?Tillotts? Business Overview
Table 111. Zeria?Tillotts? Product
Table 112. Zeria?Tillotts? Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 113. Zeria?Tillotts? Recent Development
Table 114. Perrigo Business Overview
Table 115. Perrigo Product
Table 116. Perrigo Company Details
Table 117. Perrigo Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 118. Perrigo Recent Development
Table 119. Boehringer Ingelheim Company Details
Table 120. Boehringer Ingelheim Business Overview
Table 121. Boehringer Ingelheim Product
Table 122. Boehringer Ingelheim Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 123. Boehringer Ingelheim Recent Development
Table 124. Purdue Pharma Company Details
Table 125. Purdue Pharma Business Overview
Table 126. Purdue Pharma Product
Table 127. Purdue Pharma Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 128. Purdue Pharma Recent Development
Table 129. C.B. Fleet Company Details
Table 130. C.B. Fleet Business Overview
Table 131. C.B. Fleet Product
Table 132. C.B. Fleet Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 133. C.B. Fleet Recent Development
Table 134. Abbott Company Details
Table 135. Abbott Business Overview
Table 136. Abbott Product
Table 137. Abbott Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 138. Abbott Recent Development
Table 139. Jiangzhong Company Details
Table 140. Jiangzhong Business Overview
Table 141. Jiangzhong Product
Table 142. Jiangzhong Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 143. Jiangzhong Recent Development
Table 144. Xian-Janssen Company Details
Table 145. Xian-Janssen Business Overview
Table 146. Xian-Janssen Product
Table 147. Xian-Janssen Revenue in Gastrointestinal Business (2015-2020) (Million US$)
Table 148. Xian-Janssen Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gastrointestinal Market Share by Type: 2020 VS 2026
Figure 2. Prescription Gastrointestinal Drug Features
Figure 3. OTC Gastrointestinal Drug Features
Figure 4. Global Gastrointestinal Market Share by Application: 2020 VS 2026
Figure 5. Chronic Gastritis Case Studies
Figure 6. Functional Dyspepsia Case Studies
Figure 7. Peptic Ulcer Case Studies
Figure 8. Acute Gastroenteritis Case Studies
Figure 9. Other Case Studies
Figure 10. Gastrointestinal Report Years Considered
Figure 11. Global Gastrointestinal Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Gastrointestinal Market Share by Regions: 2020 VS 2026
Figure 13. Global Gastrointestinal Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Gastrointestinal Market Share by Players in 2019
Figure 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2019
Figure 18. North America Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AstraZenec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bayer Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 35. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Teva Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 37. Zeria?Tillotts? Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Zeria?Tillotts? Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 39. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Perrigo Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 41. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 43. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 45. C.B. Fleet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 47. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Abbott Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 49. Jiangzhong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 51. Xian-Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Figure 1. Global Gastrointestinal Market Share by Type: 2020 VS 2026
Figure 2. Prescription Gastrointestinal Drug Features
Figure 3. OTC Gastrointestinal Drug Features
Figure 4. Global Gastrointestinal Market Share by Application: 2020 VS 2026
Figure 5. Chronic Gastritis Case Studies
Figure 6. Functional Dyspepsia Case Studies
Figure 7. Peptic Ulcer Case Studies
Figure 8. Acute Gastroenteritis Case Studies
Figure 9. Other Case Studies
Figure 10. Gastrointestinal Report Years Considered
Figure 11. Global Gastrointestinal Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Gastrointestinal Market Share by Regions: 2020 VS 2026
Figure 13. Global Gastrointestinal Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Gastrointestinal Market Share by Players in 2019
Figure 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2019
Figure 18. North America Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Gastrointestinal Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AstraZenec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bayer Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 35. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Teva Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 37. Zeria?Tillotts? Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Zeria?Tillotts? Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 39. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Perrigo Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 41. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 43. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 45. C.B. Fleet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 47. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Abbott Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 49. Jiangzhong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 51. Xian-Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
